The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung
- 1 March 1999
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 29 (3) , 314-322
- https://doi.org/10.1046/j.1365-2222.1999.00390.x
Abstract
Bronchoalveolar lavage (BAL) fluid from patients with birch-pollen allergy lavaged during the season showed an elevated chemotactic activity for eosinophils compared with BAL fluid from the same patients before the start of the season. The aim of this study was to identify the eosinophil chemotactic agents in the BAL fluid, to compare these findings with in vitro studies on selected cytokines, and to investigate the interactions between these cytokines. Neutralizing antibodies for interleukins (IL) -2, -5 and -8, RANTES and leukaemia inhibitory factor (LIF) were added to the BAL fluid, and the chemotactic activity was tested with eosinophils from allergic donors. Eosinophils from healthy donors were preincubated with IL-5 in order to mimic the primed state of eosinophils from allergics, and the migration towards recombinant IL-5, IL-8, and RANTES in different combinations was measured. Eosinophils from allergic donors were also used. Anti-IL-5, anti-IL-8 and anti-RANTES inhibited the chemotactic activity in the BAL fluid. Recombinant RANTES induced migration, which was enhanced by preincubation of the cells with IL-5. Only eosinophils from symptomatic allergics responded to IL-8, and IL-5 was not sufficient to prime normal eosinophils in vitro to an IL-8 response. A negative correlation was found between the level of in vivo activation of the cells and their response to IL-5, and a positive correlation with the response to RANTES. IL-8 and RANTES are important for eosinophil accumulation to the lung of pollen-allergic asthmatics. IL-5 alone may not be responsible for the priming of eosinophils in vivo, but is an essential cofactor for the other chemoattractants.Keywords
This publication has 24 references indexed in Scilit:
- Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.Journal of Clinical Investigation, 1996
- Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.The Journal of Experimental Medicine, 1994
- Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.The Journal of Experimental Medicine, 1994
- Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5APMIS, 1994
- Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjectsClinical and Experimental Allergy, 1993
- Upregulation of formyl-peptide and interleukin-8—induced eosinophil chemotaxis in patients with allergic asthmaJournal of Allergy and Clinical Immunology, 1993
- The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposureJournal of Allergy and Clinical Immunology, 1991
- Human eosinophils express functional interleukin 2 receptors.Journal of Clinical Investigation, 1991
- Current understanding of the role of the eosinophil granulocyte in asthmaClinical and Experimental Allergy, 1991
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990